HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Lee H Schwamm Selected Research

Tissue Plasminogen Activator (Alteplase)

12/2015Treatment and Outcome of Thrombolysis-Related Hemorrhage: A Multicenter Retrospective Study.
10/2015Acute Stroke: Shifting From Informed Consent to Informed Refusal of Intravenous Tissue-Type Plasminogen Activator.
4/2015Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry.
3/2015Drip and ship thrombolytic therapy for acute ischemic stroke: use, temporal trends, and outcomes.
11/2014Chronic kidney disease and bleeding complications after intravenous thrombolytic therapy for acute ischemic stroke.
10/2014Time and diffusion lesion size in major anterior circulation ischemic strokes.
10/2014Development and initial testing of the stroke rapid-treatment readiness tool.
9/2014Intravenous fibrinolysis eligibility: a survey of stroke clinicians' practice patterns and review of the literature.
9/2014Adherence to Third European Cooperative Acute Stroke Study 3- to 4.5-hour exclusions and association with outcome: data from Get with the Guidelines-Stroke.
5/2014Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Lee H Schwamm Research Topics

Disease

76Stroke (Strokes)
12/2015 - 04/2002
10Atrial Fibrillation
07/2015 - 02/2008
7Cerebral Hemorrhage
05/2013 - 02/2006
6Transient Ischemic Attack
07/2015 - 02/2006
5Coronary Artery Disease (Coronary Atherosclerosis)
04/2015 - 01/2013
5Venous Thrombosis (Deep-Vein Thrombosis)
03/2012 - 01/2009
4Hemorrhage
07/2015 - 01/2008
4Intracranial Hemorrhages (Intracranial Hemorrhage)
11/2014 - 02/2005
4Myocardial Infarction
03/2014 - 02/2006
4Heart Failure
12/2013 - 08/2011
3Sickle Cell Anemia (Hemoglobin S Disease)
01/2011 - 02/2006
3Hyperhomocysteinemia
01/2011 - 02/2006
3Patent Foramen Ovale
01/2011 - 02/2006
3Intracranial Sinus Thrombosis (Sinus Thrombosis)
01/2011 - 02/2006
2Brain Injuries (Brain Injury)
12/2014 - 03/2004
2Renal Insufficiency (Renal Failure)
11/2014 - 03/2014
1Hematoma
12/2015
1Pathologic Constriction (Stenosis)
06/2015
1Kidney Diseases (Kidney Disease)
11/2014
1Edema
08/2014
1Seizures (Seizure)
06/2014
1Hypertension (High Blood Pressure)
06/2014
1Deglutition Disorders (Dysphagia)
02/2014
1Pneumonia (Pneumonitis)
11/2013
1Aphasia (Dysphasia)
11/2013
1Heart Arrest (Cardiac Arrest)
08/2013
1Neoplasm Metastasis (Metastasis)
03/2011
1Brain Ischemia (Cerebral Ischemia)
07/2010
1Thrombosis (Thrombus)
04/2008
1Diabetes Mellitus
02/2008
1Weight Loss (Weight Reduction)
02/2008
1Dyslipidemias (Dyslipidemia)
02/2007
1Acute Coronary Syndrome
02/2006

Drug/Important Bio-Agent (IBA)

37Tissue Plasminogen Activator (Alteplase)FDA Link
12/2015 - 11/2004
6Lipoproteins (Lipoprotein)IBA
11/2014 - 02/2007
5Warfarin (Coumadin)FDA LinkGeneric
07/2015 - 01/2008
5CholesterolIBA
11/2014 - 02/2007
4AnticoagulantsIBA
07/2015 - 04/2010
4glucuronyl glucosamine glycan sulfate (Vessel)IBA
05/2013 - 04/2002
3Desmodus rotundus salivary plasminogen activator alpha 1IBA
06/2015 - 02/2009
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
04/2015 - 01/2013
3Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
04/2015 - 01/2013
3Carbon MonoxideIBA
01/2014 - 02/2006
3HormonesIBA
01/2011 - 02/2006
3Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2011 - 02/2006
2Plasminogen Activators (Plasminogen Activator)IBA
06/2015 - 02/2009
2AngiotensinsIBA
04/2015 - 01/2013
2Cytidine Triphosphate (CTP)IBA
01/2015 - 04/2002
2CreatinineIBA
11/2014 - 03/2012
2Angiotensin Receptor AntagonistsIBA
03/2014 - 01/2013
14- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA
12/2015
1Fibrinogen (Factor I)FDA Link
12/2015
1Dihydrotachysterol (AT 10)IBA
12/2015
1N(4)-oleylcytosine arabinosideIBA
07/2015
1Antidepressive Agents (Antidepressants)IBA
07/2015
1rivaroxabanIBA
07/2015
1FibrinIBA
06/2015
1tenecteplaseFDA Link
04/2015
1omega-Chloroacetophenone (Mace)IBA
01/2015
1ProgesteroneFDA LinkGeneric
12/2014
1tebufenozide (Mimic)IBA
06/2014
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
03/2014
1ORALIT (ORS)IBA
02/2014
1Brain Natriuretic Peptide (Natrecor)FDA Link
12/2013
1Anti-Bacterial Agents (Antibiotics)IBA
11/2013
1AldosteroneIBA
01/2013
1Aldosterone AntagonistsIBA
01/2013
1Blood Glucose (Blood Sugar)IBA
09/2012
1ethylene diurea (EDU)IBA
08/2011
1clopidogrel (Plavix)FDA Link
09/2010
1Elastomers (Elastomer)IBA
04/2008
1orbofibanIBA
02/2006
1Biological Markers (Surrogate Marker)IBA
03/2004
1danaproid (danaparoid)FDA Link
04/2002

Therapy/Procedure

11Thrombolytic Therapy
06/2015 - 04/2002
3Length of Stay
11/2013 - 05/2010
2Aftercare (After-Treatment)
04/2015 - 02/2005
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
04/2015 - 03/2014
1Transplants (Transplant)
04/2015
1Tracheostomy
08/2014
1Decompressive Craniectomy
08/2014
1Gastrostomy
08/2014
1Resuscitation
08/2013
1Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
06/2013
1Thrombectomy
03/2013
1Embolectomy
03/2013
1Artificial Respiration (Mechanical Ventilation)
02/2013
1Ambulatory Care (Outpatient Care)
07/2010
1Catheters
01/2010
1Intravenous Injections
07/2009
1Balloon Angioplasty
04/2008